Who owns EXELIXIS, INC. (EXEL)? Elite investor 13F holders

7 tracked elite investors reported holding EXELIXIS, INC as of 2026-06-30, including Renaissance Technologies LLC, D.E. Shaw, Caligan Partners, Gotham Asset Management, Bridgewater Associates. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

7 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of progressive and metastatic medullary…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Renaissance Technologies LLCEXELIXIS INCSHARE2026-06-302026-08-13 00:00:00730617099.00 USD13427993.000000SharesreduceOriginal filing
D.E. ShawEXELIXIS INCSHARE2026-06-302026-08-14 00:00:00302070554.00 USD5551747.000000SharesaddOriginal filing
Caligan PartnersEXELIXIS INCSHARE2026-06-302026-08-14 00:00:0084512985.00 USD1553262.000000SharesholdOriginal filing
Gotham Asset ManagementEXELIXIS INCSHARE2026-06-302026-08-14 00:00:0048569794.00 USD892663.000000SharesreduceOriginal filing
Bridgewater AssociatesEXELIXIS INCSHARE2026-06-302026-08-14 00:00:0021810738.00 USD400859.000000SharesreduceOriginal filing
GMOEXELIXIS INCSHARE2026-06-302026-08-13 00:00:000.00 USD0.000000SharesexitedOriginal filing
First Eagle Investment ManagementEXELIXIS INCSHARE2026-06-302026-08-05 00:00:00544100.00 USD10000.000000SharesholdOriginal filing
Tudor InvestmentEXELIXIS INCSHARE2026-06-302026-08-14 00:00:00252027.00 USD4632.000000SharesbuyOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown